Blog PTSD-Detail

Understanding PTSD: Symptoms and Innovative Therapies

July 30, 2025 | By Robert Setari, M.D.

Overview

Post-Traumatic Stress Disorder (PTSD) is a serious mental health condition that develops after experiencing or witnessing a traumatic event. While it is often associated with veterans and combat trauma, PTSD can affect anyone—survivors of accidents, abuse, natural disasters, or any deeply distressing situation. The impact of PTSD extends far beyond painful memories; it can disrupt relationships, impair daily functioning, and erode overall quality of life if left untreated.

What is PTSD?

PTSD occurs when the brain and nervous system remain "stuck" in survival mode after trauma. Normally, the brain processes and integrates painful experiences over time. In PTSD, however, trauma remains unresolved, resurfacing in ways that feel just as threatening as the original event. This can trigger chronic stress responses, sleep disturbances, and difficulty feeling safe—even in non-threatening environments.

Symptoms of PTSD

The symptoms of PTSD vary in intensity and may appear shortly after trauma or even years later. Common categories of symptoms include:

Intrusive Memories: Recurrent distressing thoughts, flashbacks, or nightmares about the event.
Avoidance: Steering clear of places, conversations, or activities that trigger reminders of trauma.
Negative Mood and Thinking Patterns: Feelings of guilt, shame, detachment, hopelessness, or loss of interest in once-enjoyed activities.
Hyperarousal: Heightened alertness, exaggerated startle response, irritability, difficulty sleeping, or trouble concentrating.
These symptoms can range from mild to debilitating, and their persistence often requires professional intervention to restore well-being.

Therapies for PTSD

Historically, PTSD treatment has focused on psychotherapy and medication. Evidence-based therapies such as Cognitive Behavioral Therapy (CBT) and Eye Movement Desensitization and Reprocessing (EMDR) help individuals process traumatic experiences and reduce distressing symptoms. Antidepressants and anti-anxiety medications can also provide relief, though not everyone responds fully to these approaches.

In recent years, psychedelic-assisted therapy has shown remarkable promise in treating PTSD. Substances such as MDMA and psilocybin are being studied in clinical trials for their ability to help patients revisit traumatic experiences in a safe, supportive environment. Psychedelics appear to quiet the brain's fear response and open pathways for emotional processing, allowing individuals to confront trauma without being overwhelmed. When combined with psychotherapy, this approach can foster breakthroughs that traditional methods often struggle to achieve.

Another cutting-edge treatment is Transcranial Magnetic Stimulation (TMS), a non-invasive therapy that uses magnetic fields to stimulate areas of the brain involved in mood regulation and trauma processing. For patients with PTSD, TMS can help rebalance neural circuits disrupted by trauma, leading to improved mood, reduced anxiety, and better emotional regulation. TMS is FDA-approved for depression and is increasingly being applied to PTSD with promising results—especially for those who have not found relief through medications or talk therapy alone.

Moving Forward

PTSD is not a life sentence. With the right combination of therapies, individuals can move beyond trauma and rebuild fulfilling, peaceful lives. From traditional approaches like therapy and medication to emerging innovations like psychedelic-assisted therapy and TMS, treatment options continue to expand, offering hope to those who may have felt stuck for years.

If you or someone you know is struggling with PTSD, reaching out for help is the first step toward healing. New breakthroughs are making recovery more possible than ever.

References

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author.

National Center for PTSD. (2023). Psychedelic-assisted therapy for PTSD. U.S. Department of Veterans Affairs. Retrieved from https://www.ptsd.va.gov/professional/treat/txessentials/psychedelics_assisted_therapy.asp

Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., ... & Ot’alora, G. M. (2021). MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled Phase 3 study. Nature Medicine, 27(6), 1025–1033. https://doi.org/10.1038/s41591-021-01336-3

Sheppard Pratt. (2023). Treatments for today and tomorrow: Psychedelic-assisted therapy for PTSD. Retrieved from https://www.sheppardpratt.org/insights/story/treatments-for-today-and-tomorrow/

Inserra, A., De Gregorio, D., & Gobbi, G. (2023). Psychedelic-assisted therapy and psychedelic science: Promises and pitfalls. Neurosurgery, 92(4), 543–551. https://doi.org/10.1093/neuros/nyad022

Carhart-Harris, R. L., & Nutt, D. J. (2024). Psychedelics and neuroplasticity: Rewiring the traumatized brain. arXiv preprint. https://arxiv.org/abs/2411.19840

Foa, E. B., Hembree, E. A., & Rothbaum, B. O. (2007). Prolonged exposure therapy for PTSD: Emotional processing of traumatic experiences therapist guide. Oxford University Press.

Resick, P. A., Monson, C. M., & Chard, K. M. (2017). Cognitive processing therapy for PTSD: A comprehensive manual. New York, NY: Guilford Press.

Cohen, J. A., Mannarino, A. P., & Deblinger, E. (2016). Trauma-focused CBT for children and adolescents: Treatment applications. Guilford Publications.

Lefaucheur, J. P., Aleman, A., Baeken, C., Benninger, D. H., Brunelin, J., Di Lazzaro, V., ... & Ziemann, U. (2020). Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clinical Neurophysiology, 131(2), 474–528. https://doi.org/10.1016/j.clinph.2019.11.002

Bell, J. (2024, June 5). The FDA is worried about approving MDMA therapy. Vox. Retrieved from https://www.vox.com/future-perfect/365820/mdma-therapy-lykos-therapeutics-maps-psychedelics-ecstasy